تداخل‌های دارویی
Alemtuzumab + Denosumab
شدت: متوسط
Alemtuzumab and Denosumab: moderate interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Alemtuzumab causes profound, prolonged lymphocyte depletion, and denosumab has been linked to serious infections. The combination may increase the risk of serious or opportunistic infection.
معنای این تداخل به زبان ساده
Alemtuzumab and Denosumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Alemtuzumab belongs to Miscellaneous; Denosumab belongs to Oncology.
چرا رخ می‌دهد
Additive immunosuppression from profound lymphocyte depletion by alemtuzumab and RANKL inhibition by denosumab.
اقدام لازم
Monitor closely for infection during and after alemtuzumab, and consider whether denosumab can be timed or deferred. Start prompt evaluation of any fever or infectious symptoms.
از داروساز چه بپرسید
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Alemtuzumab و Denosumab، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Denosumab
- Abatacept + Denosumab متوسط
- Adalimumab + Denosumab متوسط
- Alefacept + Denosumab متوسط
- Anakinra + Denosumab متوسط
- Azacitidine + Denosumab متوسط
- Azathioprine + Denosumab متوسط
تداخلات دیگر Alemtuzumab
پرسش‌های متداول
Can I take Alemtuzumab with Denosumab?
MediHelp rates the interaction as moderate. Alemtuzumab and Denosumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Alemtuzumab causes profound, prolonged lymphocyte depletion, and denosumab has been linked to serious infections. The combination may increase the risk of serious or opportunistic infection.
How serious is the interaction between Alemtuzumab and Denosumab?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor closely for infection during and after alemtuzumab, and consider whether denosumab can be timed or deferred. Start prompt evaluation of any fever or infectious symptoms.
What other medicines interact with Denosumab?
MediHelp also lists interactions of Denosumab with, for example, Abatacept, Adalimumab, Alefacept. The full list is on the Denosumab page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
